NASDAQ · Drug Manufacturers - Specialty & Generic

COLL (COLL) Stock

$35.58 +0.54% NASDAQ: COLL Healthcare

Valuation

MetricValue
Price$35.58
Market Cap$1.15B
P/E Ratio17.33
P/B Ratio3.75
P/S Ratio1.45
EPS (TTM)$0.00
52-Week High$50.79
52-Week Low$28.34
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE27.41%
ROA7.60%
ROCE61.92%
Gross Margin89.17%
Operating Margin15.96%
Net Margin9.41%
Debt/Equity2.59
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$277.0M$464.0M$567.0M$631.0M$781.0M
Operating Profit$18.0M$33.0M$167.0M$170.0M$187.0M
Net Profit$72.0M$-25.0M$48.0M$69.0M$63.0M
EPS$1.86$-0.74$1.29$1.86$1.73
Op Margin6.4%7.2%29.5%26.9%24.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$692.0M$1.2B$1.1B$1.7B$1.7B
Total Liabilities$489.0M$979.0M$948.0M$1.4B$1.4B
Cash$186.0M$174.0M$239.0M$71.0M$251.0M
Borrowings$259.0M$709.0M$674.0M$859.0M$941.0M

Latest News

COLL: Lowering target price to $33.00 Argus Research · Jul 15, 2026 Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? Zacks · Jul 9, 2026 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues Zacks · Jul 8, 2026 1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm StockStory · Jul 7, 2026 1 Mooning Stock to Own for Decades and 2 That Underwhelm StockStory · Jul 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$104.0M$124.0M$275.0M$205.0M$329.0M
Investing Cash Flow$-4.0M$-575.0M$-71.0M$-289.0M$-65.0M
Financing Cash Flow$-39.0M$-6.0M$-74.0M$-68.0M$-46.0M
Net Cash Flow$12.0M$-13.0M$64.0M$-143.0M$156.0M
Free Cash Flow$102.0M$123.0M$274.0M$203.0M$328.0M

Valuation & Return Ratios

MetricValue
PEG Ratio15.43
EV / EBITDA3.92
FCF Yield28.49%
Quick Ratio1.62
Interest Coverage2.28
Return 1Y9.81%
Return 3Y57.48%
Return 5Y48.89%

Ownership

Insiders Held1.16%
Institutions Held128.08%
Institutions Float Held129.58%
Institutional HolderSharesReport Date
Blackrock Inc.5,134,0272026-03-31
Janus Henderson Group PLC1,825,6512026-03-31
Invesco Ltd.1,591,9092026-03-31
Fuller & Thaler Asset Management Inc.1,499,5842026-03-31
Renaissance Technologies, LLC1,469,4492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPH $20.22 +1.40% 12.02 $891.56M 0.00%
ATAI $7.25 +0.97% -8.44 $2.68B 0.00%
CRON $2.83 -2.08% -131.00 $1.06B 0.00%
DVAXDynavax Technologies Corporation $15.50 +0.00% -40.79 $1.82B 0.00%
GDRX $3.12 +2.30% 28.44 $1.08B 0.00%

About COLL

COLL is led by CEO Vikram Karnani, employs 357 people, headquartered in US, publicly traded since 2015.

COLL stock trades at $35.58 with a market capitalization of $1.15B. The stock is valued at a price-to-earnings (P/E) ratio of 17.33, price-to-book of 3.75, price-to-sales of 1.45. Over the past 52 weeks the stock has ranged between $28.34 and $50.79, and currently trades 29.9% below its 52-week high.

On profitability, COLL generates a return on equity (ROE) of 27.41% — well above the market average, a sign of a high-quality business, return on capital employed of 61.92%, an operating margin of 15.96%, a net profit margin of 9.41%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides